Merck Annual Report 2000 Merck Annual Report 2000 [Contents]
[Products] [Financial Highlights] [Letter] [Innovation] [Access] [People] [Financials] [Management] [Corporate Info]
MANAGEMENT
More


Board of Directors

Raymond V. Gilmartin, 60
    Chairman of the Board, President and Chief Executive Officer of the Company for more than five years;
    Director, General Mills, Inc. and Public Service Enterprise Group;
    Past Chairman, Pharmaceutical Research and Manufacturers of America;
    Member, The Business Council and The Business Roundtable

H. Brewster Atwater, Jr., 69
    Retired chairman and chief executive officer of General Mills, Inc.
    
Lawrence A. Bossidy
, 66
    Retired (2000); Chairman, Honeywell International Inc. (aerospace, home and industrial controls, specialty chemicals and transportation products) (December 1999 to April 2000);
    Chairman of the Board and Chief Executive Officer, AlliedSignal, Inc. for more than five years;
    Director, J.P. Morgan Chase & Co.;
    Member, The Business Council and The Business Roundtable

William G. Bowen, Ph.D., 67
    President, The Andrew W. Mellon Foundation (philanthropic foundation) for more than five years;
    Director, American Express Company;
    Member, Board of Overseers, Teachers Insurance and Annuity Association of America-College Retirement Equities Fund;
    Trustee, Denison University

Johnnetta B. Cole, Ph.D.
, 64
    Presidential Distinguished Professor, Emory University since September 1998;
    President, Spelman College (1987 to June 1997);
    Director, Coca-Cola Enterprises;
    Trustee, Rockefeller Foundation and Gallaudet University;
    Member, Council on Foreign Relations and National Council of Negro Women;
    Fellow, American Anthropological Association

Lloyd C. Elam, M.D.
, 72
    Professor of psychiatry, Meharry Medical College.

Niall FitzGerald
, 55
    Chairman, Unilever PLC (foods, home and personal care) since September 1996; Vice-Chairman, Unilever PLC (1994 to 1996); Vice-Chairman, Unilever NV (since September 1996);
    Director, Telefonaktiebolaget LM Ericsson;
    Trustee, Leverhulme Trust;
    Member, The Business Council, The Conference Board, EU-China Business Council, Trilateral Commission and World Economic Forum

William B. Harrison, Jr.
, 57
    President and Chief Executive Officer, J.P. Morgan Chase & Co. (financial services) since January 2001;
    Chairman and Chief Executive Officer (January through December 2000), President and Chief Executive Officer (June through December 1999), Vice Chairman (1991 to December 1999), The Chase Manhattan Corporation;
    Director, J.P. Morgan Chase & Co.

William N. Kelley, M.D.
, 61
    Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine since February 2000;
    Chief Executive Officer, University of Pennsylvania Health System, Dean of the School of Medicine and Executive Vice President, University of Pennsylvania (1989 to February 2000);
    Director, Beckman Coulter, Inc.;
    Trustee, Emory University;
    Fellow, American Academy of Arts and Sciences;
    Member, American Philosophical Society, Institute of Medicine of the National Academy of Sciences;
    Master, American College of Physicians

Heidi Miller
, 47
    Vice Chairman, Marsh Inc. (risk and insurance services subsidiary of Marsh & McLennan Companies, Inc.) since January 2001;
    Senior Executive Vice President, Chief Financial Officer and Director, Priceline.com (February to November 2000);
    Chief Financial Officer, Citigroup (1998 to 2000);
    Chief Financial Officer, Travelers Group (1995 to 1998);
    Director, Bank One Corporation, General Mills, Inc. and Mead Corporation;
    Trustee, Princeton University and NYU Medical School

Edward M. Scolnick, M.D.
, 60
    Executive Vice President, Science and Technology and President, Merck Research Laboratories (MRL) for more than five years;
    September 1994 - executive vice president (since January, 1993), Science and Technology and president, MRL (since May, 1985): responsible for worldwide research function and activities of Merck Manufacturing Division (since December, 1993), computer resources (since January, 1993) and corporate licensing;
    Member, National Academy of Sciences and its Institute of Medicine

Anne M. Tatlock
, 61
    Chairman (since June 2000) and Chief Executive Officer (since September 1999), Fiduciary Trust Company International (global asset management services); President (1994 to 2000) Fiduciary Trust Company International;
    Director, American General Corporation, Fortune Brands, Inc. and Franklin Resources, Inc.;
    Chairman, Cultural Institutions Retirement Systems;
    President, American Ballet Theatre Foundation;
    Trustee, The Andrew W. Mellon Foundation, Howard Hughes Medical Institute, Teagle Foundation and Vassar College

Samuel O. Thier, M.D., 63
    President (since April 1997) and Chief Executive Officer (since July 1996), Partners HealthCare System, Inc.;
    President, Massachusetts General Hospital (May 1994 to April 1997);
    Director, Partners HealthCare System, Inc. and Charles River Laboratories, Inc.;
    Member, Institute of Medicine of the National Academy of Sciences;
    Fellow, American Academy of Arts and Sciences;
    Trustee, Boston Museum of Science, Cornell University, The Commonwealth Fund and WGBH Public Television;
    Master, American College of Physicians

Dennis Weatherstone
, 70
    Retired chairman of J.P. Morgan & Co. Incorporated and Morgan Guaranty Trust Company of New York

Back to Board of Directors

[Contents]
[Products] [Financial Highlights] [Letter] [Innovation] [Access] [People] [Financials] [Management] [Corporate Info]
Merck Annual Report 2000 Merck Annual Report 2000
Copyright © 1995-2001 Merck & Co., Inc., Whitehouse Station, NJ, USA. All rights reserved.

Board of DirectorsManagement Committee